Outlook Therapeutics Inc. (OTLK)
Market Closed
17 Jul, 20:00
$
1. 39
-0.07
-4.7945%
$
64.59M Market Cap
- P/E Ratio
- Div Yield
9.63M Volume
-0.23 Eps
$ 1.46
Previous Close Want to track OTLK and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Outlook Therapeutics Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| JD Jim Dushek HARBOUR INVESTMENTS Inc. | 12,304 | $16,874.4 | $19,378.8 | $2,504.4 | 14.84% |
 Anthony Scaramucci SkyBridge Capital II LLC | 4.17M | $857,773.98 | $6.59M | $5.73M | 667.74% |
 Point72 Asset Management LP Point72 Asset Management LP | 29,038 | $5,976 | $45,592.56 | $39,616.56 | 662.93% |
 Leonid Berline ARMSTRONG ADVISORY GROUP Inc. | 179 | $1,322 | $265.81 | -$1,056.19 | -79.89% |
| DP Drew Phillips Fortitude Family Office LLC | 2,554 | $1,108.68 | $3,860.37 | $2,751.69 | 248.2% |
| MA Marie-Andree Alain Federation des caisses Desjardins du Quebec | 1,312 | $1,601 | $1,830.24 | $229.24 | 14.32% |
 Robin Gould Christensen, King & Associates Investment Services, Inc. | 28,327 | $81,759.14 | $39,657.8 | -$42,101.34 | -51.49% |
